The analysis of different factors that influence the clinical outcome of ALL patients in our study showed that only GSTO2 SNP seemed to impact the survival outcome of patients as carriers of its homozygous variant GG had significantly lower DFS (log-rank p = 0.002). Here, GSTO2 is linked to acute lymphoblastic leukemia.